Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.49 |
| ▸ | MEN1 | O00255 | 4/20 | 0.49 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.46 |
| ▸ | GBA1 | P04062 | 4/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1091507 | 0.86 | SMN1; SMN2 (0.54) | SMN1; SMN2MAPK1KMT2AMEN1LMNA | |
| SCHEMBL777910 | 0.83 | SMN1; SMN2 (0.51) | SMN1; SMN2MAPK1KMT2AMEN1LMNA | |
| SCHEMBL13625150 | 0.79 | HTT (0.55) | SMN1; SMN2MAPK1KMT2AMEN1LMNA | |
| SCHEMBL778332 | 0.76 | SMN1; SMN2 (0.52) | SMN1; SMN2MAPK1KMT2AMEN1LMNA | |
| SCHEMBL28998684 | 0.76 | SMN1; SMN2 (0.58) | SMN1; SMN2MAPK1KMT2AMEN1LMNA | |
| SCHEMBL1090112 | 0.76 | SMN1; SMN2 (0.58) | SMN1; SMN2MAPK1KMT2AMEN1LMNA | |
| SCHEMBL2242665 | 0.76 | SMN1; SMN2 (0.52) | SMN1; SMN2MAPK1KMT2AMEN1LMNA | |
| SCHEMBL8422457 | 0.76 | SMN1; SMN2 (0.58) | SMN1; SMN2MAPK1KMT2AMEN1LMNA | |
| SCHEMBL1100636 | 0.75 | LMNA (0.60) | SMN1; SMN2MAPK1KMT2AMEN1LMNA | |
| SCHEMBL28769756 | 0.75 | LMNA (0.67) | SMN1; SMN2KMT2AMEN1LMNANPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090281215-A1 | Polytriazinyl Compounds as Flame Retardants and Light Stabilizers | MCA TECHNOLOGIES GMBH (CH) | 2009-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090281215-A1 | Polytriazinyl Compounds as Flame Retardants and Light Stabilizers | PSMB5, POLL, F12 | SMN1; SMN2 1885/4885MAPK1 3238/4885KMT2A 3021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.